Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma (Q34014712)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma |
scientific article |
Statements
1 reference
Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma (English)
1 reference
M V Kopp
1 reference
E Hamelmann
1 reference
S Zielen
1 reference
W Kamin
1 reference
K-C Bergmann
1 reference
C Sieder
1 reference
S Stenglein
1 reference
S Seyfried
1 reference
U Wahn
1 reference
DUAL study group
1 reference
30 October 2008
1 reference
1 reference
39
1 reference
271-279
1 reference
Identifiers
1 reference
1 reference